Accueil
Explorer
nav.journalClub
Tendances
Plus
synapse
⌘+K
Langue
Français
De novo transcriptome sequencing of Artemisia absinthium predicted anti-SARS-CoV2 (COVID-19) bioactive secondary metabolites | Synapse
March 3, 2026
De novo transcriptome sequencing of Artemisia absinthium predicted anti-SARS-CoV2 (COVID-19) bioactive secondary metabolites
UK
Umar Khitab Khan
AA
Awais ALi
CL
Chunhua Li
Chinese Academy of Sciences
See all
Key Points
Bioactive secondary metabolites predicted to inhibit SARS-CoV2 have been identified.
Key evidence includes specific metabolites associated with antiviral activity against COVID-19.
Analysis focuses on de novo transcriptome sequencing of Artemisia absinthium to discover new compounds.
These findings may highlight new avenues for COVID-19 treatment and herbal medicine applications.
Mark Helpful
Like
Save
Bookmark
Relay
Share
Cite This Study
Copy
Khan et al. (Wed,) studied this question.
synapsesocial.com/papers/69a75d4fc6e9836116a271db
https://doi.org/https://doi.org/10.1007/s44473-025-00029-w
Mark Helpful
Like
Save
Bookmark
Relay
Share